Merck & Co., Inc.

Merck & Co., Inc. is a leading healthcare company that operates worldwide. Established in 1891, the company is headquartered in Kenilworth, New Jersey and is established as a leader in pharmaceuticals and animal health products. The company operates through two distinct segments – Pharmaceutical and Animal Health – and offers a range of human health products, veterinary pharmaceuticals, vaccines and health management solutions and services. Merck’s Pharmaceutical segment focuses on areas such as oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes and also provides pediatric, adolescent and adult vaccines. Its Animal Health segment offers veterinary pharmaceuticals, vaccines, health management solutions and services, as well as connected identification products for traceability and monitoring. Merck has collaborative partnerships with several leading companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics and Gilead Sciences, Inc. to provide long-acting treatments for HIV.

Merck & Co., Inc. is a leading global healthcare company that seeks to make a difference in people’s lives by developing and delivering a broad range of innovative products and services. The company employs almost 70,000 individuals in more than 140 countries. Merck has a portfolio of over 80 different prescription medicines and 17 vaccines and provides services and products to more than 350 million people in over 120 countries. Merck’s research and development activities focus on addressing needs in metabolic diseases, oncology, neuroscience and vaccine research, among other areas. The company is actively committing its resources to researching new treatments for some of the world’s most serious diseases, including HIV, cancer and Alzheimer’s. Merck is also actively partnering with other organizations to develop more effective treatments and healthcare solutions.